ResMed Inc (RMD) Thursday reported third-quarter net earnings of $83.3 million or $0.58 per share compared with $80.9 million or $0.56 per share last year.
Revenues for the quarter were up 6% at $380.4 million compared with $357.7 million in the prior year.
Analysts polled by Thomson Reuters estimated earnings of $0.58 per share on revenues of $374.8 million for the quarter. Analysts' estimates typically exclude special items.
"We had a successful start to fiscal year 2015, as new product launches drove revenue growth," said Mick Farrell, ResMed's chief executive officer. "Our results showed very strong performance from our European and Asia Pacific regions, as well as solid growth in the Americas."
ResMed declared a quarterly dividend of $0.28 per share.
ResMed makes medical equipment for treating managing sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic diseases.
For comments and feedback contact: editorial@rttnews.com
Business News